Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

Autor: Matthew Salmon, Helen E. White, Hana Zizkova, Andrea Gottschalk, Eliska Motlova, Nuno Cerveira, Dolors Colomer, Daniel Coriu, Georg N. Franke, Enrico Gottardi, Barbara Izzo, Tomas Jurcek, Thomas Lion, Vivien Schäfer, Claudia Venturi, Paolo Vigneri, Magdalena Zawada, Jan Zuna, Lenka Hovorkova, Jitka Koblihova, Hana Klamova, Marketa Stastna Markova, Dana Srbova, Adela Benesova, Vaclava Polivkova, Daniela Zackova, Jiri Mayer, Ingo Roeder, Ingmar Glauche, Thomas Ernst, Andreas Hochhaus, Katerina Machova Polakova, Nicholas C. P. Cross

Several studies have reported that chronic myeloid leukaemia (CML) patients expressing e14a2 BCR::ABL1 have a faster molecular response to therapy compared to patients expressing e13a2. To explore the reason for this difference we undertook a detaile

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c7e78efc803971af05ba5788bfd9a40
https://eprints.soton.ac.uk/467300/

Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients.

Autor: Folta, Adam¹ (AUTHOR), Jurcek, Tomas¹ (AUTHOR), Kubesova, Blanka¹ (AUTHOR), Zackova, Daniela^1,2 (AUTHOR), Semerad, Lukas^1,2 (AUTHOR), Mayer, Jiri^1,2,3 (AUTHOR), Jeziskova, Ivana^1,2 (AUTHOR)

Publikováno v: Leukemia & Lymphoma. May2021, Vol. 62 Issue 5, p1239-1242. 4p.

Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow‐up.

Autor: Romzova, Marianna, Smitalova, Dagmar, Hynst, Jakub, Tom, Nikola, Loja, Tomas, Herudkova, Zdenka, Jurcek, Tomas, Stejskal, Lukas, Zackova, Daniela, Mayer, Jiri, Racil, Zdenek, Culen, Martin

Publikováno v: British Journal of Haematology; Aug2021, Vol. 194 Issue 3, p604-612, 9p

The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy.

Autor: Malcikova, Jitka^1,2 (AUTHOR), Razga, Filip² (AUTHOR), Jurcek, Tomas² (AUTHOR), Dvorakova, Dana^1,2 (AUTHOR), Zackova, Daniela² (AUTHOR), Toskova, Martina² (AUTHOR), Sebejova, Ludmila² (AUTHOR), Smardova, Jana³ (AUTHOR), Oltova, Alexandra² (AUTHOR), Vankova, Gabriela² (AUTHOR), Jurackova, Lenka² (AUTHOR), Trbusek, Martin^1,2 (AUTHOR), Pospisilova, Sarka^1,2 (AUTHOR), Mayer, Jiri^1,2 (AUTHOR), Racil, Zdenek^1,2 (AUTHOR) zracil@fnbrno.cz

Publikováno v: Leukemia & Lymphoma. Sep2013, Vol. 54 Issue 9, p2083-2087. 5p.

University Hospital Brno and Masaryk University Researcher Yields New Findings on Chronic Myeloid Leukemia [Real World Population- Based Data from Nationwide Registry Support the Existence of Accelerated Phase in Newly Diagnosed Chronic Myeloid...].

Publikováno v: Women's Health Weekly; 12/19/2023, p2320-2320, 1p